Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter
- PMID: 12213402
- DOI: 10.1016/s0264-410x(02)00310-9
Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter
Abstract
The objective of this study was to compare immune responses induced against HIV-1 Nef after DNA immunization with Nef encoding plasmids under the control of an ubiquitous or a muscle-specific promoter. To this end, plasmids containing HIV-1 nef under the control of the Cytomegalovirus or the human desmin promoters, specifically expressed in muscle cells, were constructed. Different groups of BALB/c mice were immunized with 10 or 100 microg of both constructs, controls were the pcDNA3 vector or the Nef protein in Freund's adjuvant (Nef-CFA). Our data showed that both plasmids stimulated anti-Nef humoral responses in a dose-dependent manner. The anti-Nef antibody response, however, was earlier and higher with the CMV-IE promoter than with the desmin promoter. We also showed that Nef expressing plasmids induced high titers of anti-Nef antibodies (10(4)), comparable to those obtained in the Nef-CFA group (4x10(4)). Analysis of the specificity of anti-Nef antibodies revealed no influence of the promoter, and in contrast to Nef-CFA, plasmid immunization elicited anti-Nef antibodies directed principally against conformational-dependent epitopes. Data on the lymphoproliferative response showed that the specificity of expression, or the plasmid dose, did not affect the onset-time or the intensity of the response. The predominant IgG2a isotype of anti-Nef antibodies and the cytokine profile, mostly IL-2 and IFN-gamma, produced by Nef-stimulated spleen cells indicated a Th1 response in plasmid-immunized mice, in contrast to mice immunized with Nef-CFA, where a Th2 response was induced. In conclusion, these data indicate that antigen expression by muscle cells is sufficient to stimulate a Th1 immune response.
Similar articles
-
Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.Mol Immunol. 2002 Jan;38(8):607-18. doi: 10.1016/s0161-5890(01)00096-7. Mol Immunol. 2002. PMID: 11792429
-
Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein.Vaccine. 1998 Oct;16(16):1523-30. doi: 10.1016/s0264-410x(98)00036-x. Vaccine. 1998. PMID: 9711799
-
Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.Vaccine. 2001 Apr 6;19(20-22):2803-11. doi: 10.1016/s0264-410x(01)00004-4. Vaccine. 2001. PMID: 11282190
-
Towards new mycobacterial vaccines.Dev Biol Stand. 1994;82:171-8. Dev Biol Stand. 1994. PMID: 7958472 Review.
-
The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck.Res Virol. 1997 Jan-Feb;148(1):52-8. doi: 10.1016/s0923-2516(97)81914-0. Res Virol. 1997. PMID: 9017835 Review. No abstract available.
Cited by
-
Subcutaneous administration CpG-ODNs acts as a potent adjuvant for an HIV-1-tat-based vaccine candidate to elicit cellular immunity in BALB/c mice.Biotechnol Lett. 2018 Mar;40(3):527-533. doi: 10.1007/s10529-017-2497-9. Epub 2018 Jan 8. Biotechnol Lett. 2018. PMID: 29313255
-
Technologies for enhanced efficacy of DNA vaccines.Expert Rev Vaccines. 2012 Feb;11(2):189-209. doi: 10.1586/erv.11.188. Expert Rev Vaccines. 2012. PMID: 22309668 Free PMC article. Review.
-
DNA vaccines: ready for prime time?Nat Rev Genet. 2008 Oct;9(10):776-88. doi: 10.1038/nrg2432. Nat Rev Genet. 2008. PMID: 18781156 Free PMC article. Review.
-
Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNA.J Virol. 2005 Dec;79(23):14688-97. doi: 10.1128/JVI.79.23.14688-14697.2005. J Virol. 2005. PMID: 16282469 Free PMC article.
-
A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.J Virol. 2005 Mar;79(6):3419-28. doi: 10.1128/JVI.79.6.3419-3428.2005. J Virol. 2005. PMID: 15731236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical